文献速递肝病

无创评分系统识别普通人群中重度肝病风险个体的能力

Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease.
PubMed 文献 · Gastroenterology · 2019-09-26

该研究基于瑞典Apolipoprotein Mortality Risk队列中35至79岁人群的数据,评估APRI、BARD、FIB-4、Forns和NFS等无创评分系统预测未来肝相关事件的能力。结果显示,评分较高与肝硬化风险增加相关,但预测能力一般,在随访时间较短和NAFLD风险较高的人群中表现更好,AUROC可达0.83。

要点

  • 无创评分高分与普通人群肝硬化风险增加相关,但预测能力有限。
  • 预测能力随时间下降,在男性中较高,在NAFLD风险高者中更准。
  • 需要新的评分系统用于普通人群和初级保健中的纤维化风险评估。

核心结论

  • 无创评分系统评分较高与普通人群肝硬化风险增加相关,但预测能力一般。
  • 在随访时间较短和NAFLD风险较高的人群中预测表现更好,AUROC可达0.83。
  • 需要新的评分系统来评估普通人群和初级保健中的纤维化风险。

研究设计与样本

  • 研究基于瑞典Apolipoprotein Mortality Risk队列,纳入1985至1996年采集血样的35至79岁人群。
  • APRI样本量127,302,BARD为75,303,FIB-4为126,941,Forns为122,419,NFS为13,160。
  • 通过链接瑞典健康数据登记确定肝硬化或并发症的发病病例,使用Cox回归估计5年、10年和最长27年随访的重度肝病风险比。
  • 使用AUROC曲线和C-statistics分析评估评分的预测能力。

主要发现

  • 各评分系统评估的人群中,发生肝硬化或其并发症的比例相似,为1.0%至1.4%。
  • 与低风险组相比,中风险和高风险组的任何结局发生率均增加,10年随访时高风险组的HR从BARD评分的1.67到APRI评分的45.9。
  • 所有评分系统的预测能力随时间下降,且在男性中更高。
  • 所有评分系统在基线有NAFLD风险因素的人群中更准确,AUROC可达0.83。

临床怎么用

  • 无创评分系统可用于普通人群肝硬化风险分层,但预测能力有限,需结合临床判断。
  • 在NAFLD风险较高的人群中,评分系统的预测准确性更高,可优先考虑使用。
  • 随访时间较短时评分预测表现更好,提示动态监测可能有益。

局限性

  • 预测能力一般,随时间下降。
  • 需要在普通人群和初级保健中开发新的评分系统。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Noninvasive scoring systems are used to identify persons with advanced liver fibrosis. We investigated the ability of scoring systems to identify individuals in the general population at risk for future liver-related events. METHODS: We collected data from the Swedish Apolipoprotein Mortality Risk cohort on persons 35 to 79 years old who had blood samples collected from 1985 through 1996. We collected APRI (n = 127,302), BARD (n = 75,303), FIB-4 (n = 126,941), Forns (n = 122,419), and the nonalcoholic fatty liver disease (NAFLD) fibrosis scores (NFS, n = 13,160). We ascertained incident cases of cirrhosis or complications by linking Swedish health data registers. Cox regression was used to estimate hazard ratios (HRs) for severe liver disease at 5, 10, and a maximum follow-up time of 27 years. The predictive ability of the scores was evaluated using area under the receiver operating characteristic (AUROC) curve and C-statistics analyses. Our specific aims were to investigate the predictive capabilities of scoring systems for fatal and nonfatal liver disease, determine which scoring system has the highest level of accuracy, and investigate the predictive abilities of the scoring systems in persons with a higher probability of NAFLD at baseline. RESULTS: A similar proportion of individuals evaluated by each scoring system developed cirrhosis or complications thereof (1.0%-1.4%). The incidence of any outcome was increased in intermediate- and high-risk groups compared with low-risk groups, with HRs at 10 years in the high-risk group ranging from 1.67 for the BARD score to 45.9 for the APRI score. The predictive abilities of all scoring systems decreased with time and were higher in men. All scoring systems were more accurate in persons with risk factors for NAFLD at baseline, with AUROCs reaching 0.83. CONCLUSIONS: Higher scores from noninvasive scoring systems to evaluate fibrosis are associated with an increased risk of cirrhosis in a general population, but their predictive ability is modest. Performance was better when patients were followed for shorter time periods and in persons with a higher risk of NAFLD, with AUROC values reaching 0.83. New scoring systems are needed to evaluate risk of fibrosis in the general population and in primary care.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hagström H, Talbäck M, Andreasson A, et al. Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease. Gastroenterology. 2019. PMID: 31563624. doi:10.1053/j.gastro.2019.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。